Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of Surgical Oncology

Topics

Medicine

Cancer Oncology

Epidemiology

Internal Medicine

Surgery

Show all topics

DOI

10.1245/s10434-024-15632-y

License

CC-BY

Other Formats

PDF